SEARCH

SEARCH BY CITATION

References

  • 1
    Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978984.
  • 2
    McDougal LK, Steward CD, Killgore GE et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41: 51135120.
  • 3
    Tenover FC, McDougal LK, Goering RV et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44: 108118.
  • 4
    Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009; 64: 441446.
  • 5
    Jenkins TC, McCollister BD, Sharma R et al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 2009; 30: 233241.
  • 6
    Kreisel KM, Stine OC, Johnson JK et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? Diagn Microbiol Infect Dis 2011; 70: 285290.
  • 7
    McCaskill ML, Mason EO Jr, Kaplan SL et al. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 2007; 26: 11221127.
  • 8
    Patel M, Waites KB, Hoesley CJ et al. Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. J Hosp Infect 2008; 68: 208213.
  • 9
    D’Agata EM, Webb GF, Horn MA et al. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009; 48: 274284.
  • 10
    Skov RL, Jensen KS. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009; 73: 364370.
  • 11
    Desai R, Pannaraj PS, Agopian J et al. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites. Am J Infect Control 2011; 39: 219225.
  • 12
    Roberts MC, Soge OO, No D, Helgeson SE, Meschke JS. Characterization of methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. J Appl Microbiol 2011; 110: 15311537.
  • 13
    Uhlemann AC, Knox J, Miller M et al. The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One 2011; 6: e22407.
  • 14
    Diep BA, Stone GG, Basuino L et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 2008; 197: 18.
  • 15
    Reyes J, Rincon S, Diaz L et al. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 2009; 49: 18611867.
  • 16
    Simor AE, Gilbert NL, Gravel D et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national Surveillance and Changing Epidemiology, 1995–2007. Infect Control Hosp Epidemiol 2010; 31: 348356.
  • 17
    Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 2008; 198: 336343.
  • 18
    Christianson S, Golding GR, Campbell J, Mulvey MR. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007; 45: 19041911.
  • 19
    Ofner-Agostini M, Simor AE, Mulvey M et al. Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infect Control Hosp Epidemiol 2006; 27: 204207.
  • 20
    Adam HJ, Allen VG, Currie A et al. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. Can J Emerg Med 2009; 11: 439446.
  • 21
    Gilbert M, Macdonald J, Louie M et al. Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. Can J Infect Dis Med Microbiol 2007; 18: 357362.
  • 22
    Gilbert M, MacDonald J, Gregson D et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Can Med Assoc J 2006; 175: 149154.
  • 23
    Vayalumkal J, Suh K, Toye B et al. The epidemiology of skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in patients presenting to the Ottawa Hospital. Int J Antimicrob Agents 2009; 34 (suppl 2): S10.
  • 24
    Twele L, Moyen E, Zhang K et al. Methicillin-resistant Staphylococcus aureus endocarditis and de novo development of daptomycin resistance during therapy. Can J Infect Dis Med Microbiol 2010; 21: 8993.
  • 25
    Kim J, Ferrato C, Golding GR et al. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008. Epidemiol Infect 2011; 139: 10091018.
  • 26
    Saunders A, Panaro L, McGeer A et al. A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol 2007; 18: 128132.
  • 27
    Vayalumkal JV, Whittingham H, Vanderkooi O et al. Necrotizing pneumonia and septic shock: suspecting CA-MRSA in patients presenting to Canadian emergency departments. Can J Emerg Med 2007; 9: 300303.
  • 28
    Wilmer A, Lloyd-Smith E, Romney M et al. Methicillin-resistant Staphylococcus aureus strain USA300 is prevalent among hospital-onset cases in an urban Canadian setting. Infect Control Hosp Epidemiol 2011; 32: 12271229.
  • 29
    Nichol KA, Adam HJ, Hussain Z et al. Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study. Diagn Microbiol Infect Dis 2011; 69: 320325.
  • 30
    Alvarez CA, Barrientes OJ, Leal AL et al. Community-associated methicillin-resistant Staphylococcus aureus, Colombia. Emerg Infect Dis 2006; 12: 20002001.
  • 31
    Arias CA, Rincon S, Chowdhury S et al. MRSA USA300 clone and VREF—a US–Colombian connection? N Engl J Med 2008; 359: 21772179.
  • 32
    Alvarez CA, Yomayusa N, Leal AL et al. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia. Am J Infect Control 2010; 38: 315318.
  • 33
    Garcia C, Deplano A, Denis O et al. Spread of community-associated methicillin-resistant Staphylococcus aureus to Peru. J Infect 2011; 63: 482483.
  • 34
    Monecke S, Nitschke H, Slickers P et al. Molecular epidemiology and characterisation of MRSA isolates from Trinidad and Tobago. Eur J Clin Microbiol Infect Dis 2011, Nov 9. [Epub ahead of print].
  • 35
    Sola C, Paganini H, Egea AL et al. Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children. PLoS One 2012; 7: e30487.
  • 36
    Schuenck RP, Nouer SA, Winter Cde O et al. Polyclonal presence of non-multiresistant methicillin-resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associated infections in a hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis 2009; 64: 434441.
  • 37
    Velazquez-Meza ME, Ayala-Gaytan J, Carnalla-Barajas MN et al. First report of community-associated methicillin-resistant Staphylococcus aureus (USA300) in Mexico. J Clin Microbiol 2011; 49: 30993100.
  • 38
    Arriola CS, Guere ME, Larsen J et al. Presence of methicillin-resistant Staphylococcus aureus in pigs in Peru. PLoS One 2011; 6: e28529.
  • 39
    Larsen A, Stegger M, Goering R et al. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000–2005). Euro Surveill 2007; 12: 2224.
  • 40
    Armand-Lefevre L, Buke C, Ruppe E et al. Secular trends and dynamics of hospital-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2010; 16: 14351441.
  • 41
    Blanco R, Tristan A, Ezpeleta G et al. Molecular epidemiology of Panton–Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population. J Clin Microbiol 2011; 49: 433436.
  • 42
    Huijsdens XW, Janssen M, Renders NH et al. Methicillin-resistant Staphylococcus aureus in a beauty salon, the Netherlands. Emerg Infect Dis 2008; 14: 17971799.
  • 43
    Kearns AM, Ganner M, Hill RL et al. Community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales. Int J Antimicrob Agents 2007; 29 (suppl 2): S27.
  • 44
    Marimon JM, Villar M, Garcia-Arenzana JM et al. Molecular characterization of Staphylococcus aureus carrying the Panton–Valentine leucocidin genes in northern Spain. J Infect 2012; 64: 4753.
  • 45
    Rossney AS, Shore AC, Morgan PM et al. The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton–Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J Clin Microbiol 2007; 45: 25542563.
  • 46
    Ruppitsch W, Stoger A, Schmid D et al. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill 2007; 12: pii: 3294.
  • 47
    Baldan R, Tassan Din C, Semeraro G et al. Severe community-onset infections in healthy individuals caused by community-acquired MRSA in an Italian teaching hospital, 2006–2008. J Hosp Infect 2009; 72: 271273.
  • 48
    Cercenado E, Ruiz de Gopegui E. Community-acquired methicillin-resistant Staphylococcus aureus. Enferm Infecc Microbiol Clin 2008; 26 (suppl 13): 1924.
  • 49
    Larsen AR, Goering R, Stegger M et al. Two distinct clones of methicillin-resistant Staphylococcus aureus (MRSA) with the same USA300 pulsed-field gel electrophoresis profile: a potential pitfall for identification of USA300 community-associated MRSA. J Clin Microbiol 2009; 47: 37653768.
  • 50
    Grundmann H, Aanensen DM, van den Wijngaard CC et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010; 7: e1000215.
  • 51
    Manzur A, Dominguez AM, Pujol M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008; 14: 377380.
  • 52
    Krziwanek K, Metz-Gercek S, Mittermayer H. Trends in the occurrence of MRSA strains in Upper Austria from 2006 to 2009. Clin Microbiol Infect 2011; 17: 920923.
  • 53
    Petersson AC, Olsson-Liljequist B, Miorner H, Haeggman S. Evaluating the usefulness of spa typing, in comparison with pulsed-field gel electrophoresis, for epidemiological typing of methicillin-resistant Staphylococcus aureus in a low-prevalence region in Sweden 2000–2004. Clin Microbiol Infect 2010; 16: 456462.
  • 54
    Rodriguez-Bano J, Angeles Dominguez M, Blas Millan A et al. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain. Clin Microbiol Infect 2009; 15: 11111118.
  • 55
    Wannet WJ, Spalburg E, Heck ME et al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton–Valentine leucocidin genes in The Netherlands. J Clin Microbiol 2005; 43: 33413345.
  • 56
    Witte W, Strommenger B, Cuny C et al. Methicillin-resistant Staphylococcus aureus containing the Panton–Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007; 60: 12581263.
  • 57
    Elston JW, Meigh J, Kearns AM et al. Community-associated meticillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK. J Hosp Infect 2009; 72: 307313.
  • 58
    Naesens R, Ronsyn M, Druwe P et al. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. J Med Microbiol 2009; 58: 12471251.
  • 59
    Obando I, Valderrabanos ES, Millan JA, Neth OW. Necrotising pneumonia due to influenza A (H1N1) and community-acquired methicillin-resistant Staphylococcus aureus clone USA300: successful management of the first documented paediatric case. Arch Dis Child 2010; 95: 305306.
  • 60
    Sanchini A, Campanile F, Monaco M et al. DNA microarray-based characterisation of Panton–Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy. Eur J Clin Microbiol Infect Dis 2011; 30: 13991408.
  • 61
    Valentini P, Parisi G, Monaco M et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 2008; 7: 11.
  • 62
    Haenni M, Saras E, Chatre P et al. A USA300 variant and other human-related methicillin-resistant Staphylococcus aureus strains infecting cats and dogs in France. J Antimicrob Chemother 2012; 67: 326329.
  • 63
    Huang XZ, Cash DM, Chahine MA et al. Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq. Epidemiol Infect 2011; 139: 994997.
  • 64
    Murray CK, Griffith ME, Mende K et al. Methicillin-resistant Staphylococcus aureus in wound cultures recovered from a combat support hospital in Iraq. J Trauma 2010; 69 (suppl 1): S102S108.
  • 65
    Glikman D, Davidson S, Kudinsky R et al. First isolation of SCCmec IV- and Panton–Valentine leukocidin-positive, sequence type 8, community-associated methicillin-resistant Staphylococcus aureus in Israel. J Clin Microbiol 2010; 48: 38273828.
  • 66
    Fan H, Li H, Wang L. Three cases of community-associated meticillin-resistant Staphylococcus aureus infection in China. J Med Microbiol 2008; 57: 11781179.
  • 67
    Park C, Lee DG, Kim SW et al. Predominance of community-associated methicillin-resistant Staphylococcus aureus strains carrying staphylococcal chromosome cassette mec type IVA in South Korea. J Clin Microbiol 2007; 45: 40214026.
  • 68
    Shibuya Y, Hara M, Higuchi W et al. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J Infect Chemother 2008; 14: 439441.
  • 69
    Higashiyama M, Ito T, Han X et al. Epidural abscess caused by community-associated methicillin-resistant Staphylococcus aureus strain USA300 in Japan. J Infect Chemother 2010; 16: 345349.
  • 70
    Higuchi W, Mimura S, Kurosawa Y et al. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan. J Infect Chemother 2010; 16: 292297.
  • 71
    Mine Y, Higuchi W, Taira K et al. Nosocomial outbreak of multidrug-resistant USA300 methicillin-resistant Staphylococcus aureus causing severe furuncles and carbuncles in Japan. J Dermatol 2011; 38: 11671171.
  • 72
    Nagao M, Iinuma Y, Suzuki M et al. First outbreak of methicillin-resistant Staphylococcus aureus USA300 harboring the Panton–Valentine leukocidin genes among Japanese health care workers and hospitalized patients. Am J Infect Control 2010; 38: e37e39.
  • 73
    Monecke S, Ehricht R, Slickers P et al. The molecular epidemiology and evolution of the Panton–Valentine leukocidin-positive, methicillin-resistant Staphylococcus aureus strain USA300 in Western Australia. Clin Microbiol Infect 2009; 15: 770776.
  • 74
    Gottlieb T, Su WY, Merlino J, Cheong EY. Recognition of USA300 isolates of community-acquired methicillin-resistant Staphylococcus aureus in Australia. Med J Aust 2008; 189: 179180.
  • 75
    Coombs GW, Nimmo GR, Pearson JC et al. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell 2009; 33: 1020.
  • 76
    Coombs GW, Pearson JC, Christiansen KJ, Nimmo GR. Staphylococcus aureus Programme 2010: Community Survey, MRSA Epidemiology and Typing Report: Australian Group for Antimicrobial Resistance; 2011. Available at: http://www.agargroup.org/surveys (last accessed 14 March 2012).
  • 77
    Alesana-Slater J, Ritchie SR, Heffernan H et al. Methicillin-resistant Staphylococcus aureus, Samoa, 2007–2008. Emerg Infect Dis 2011; 17: 10231029.
  • 78
    Richardson A, Desai U, Mowat E et al. Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2010. 2011. Available at: http://www.surv.esr.cri.nz/antimicrobial/mrsa_annual.php.b (last accessed 10 February 2012).
  • 79
    Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 25 (suppl): 7479.
  • 80
    Robinson DA, Kearns AM, Holmes A et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005; 365: 12561258.
  • 81
    Lin Y, Barker E, Kislow J et al. Evidence of multiple virulence subtypes in nosocomial and community-associated MRSA genotypes in companion animals from the upper midwestern and northeastern United States. Clin Med Res 2011; 9: 716.
  • 82
    Uhlemann AC, Dumortier C, Hafer C et al. Molecular characterization of Staphylococcus aureus from outpatients in the Caribbean reveals the presence of pandemic clones. Eur J Clin Microbiol Infect Dis 2011; 31: 505511.
  • 83
    Hopman J, Torano Peraza G, Espinosa F et al. Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba. BMC Proc 2011; 5 (suppl 6): 172.
  • 84
    Wannet WJ, Heck ME, Pluister GN et al. Panton–Valentine leukocidin positive MRSA in 2003: the Dutch situation. Euro Surveill 2004; 9: 2829.
  • 85
    Tietz A, Frei R, Widmer AF. Transatlantic spread of the USA300 clone of MRSA. N Engl J Med 2005; 353: 532533.
  • 86
    Denis O, Deplano A, De Beenhouwer H et al. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton–Valentine leucocidin genes in Belgium. J Antimicrob Chemother 2005; 56: 11031106.
  • 87
    Huijsdens XW, van Santen-Verheuvel MG, Spalburg E et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44: 29942996.
  • 88
    Hedin G, Fang H. Epidemiology of methicillin-resistant Staphylococcus aureus in Southern Stockholm, 2000–2003. Microb Drug Resist 2007; 13: 241250.
  • 89
    Nashev D, Bizeva L, Toshkova K. First cases of infections caused by Panton–Valentine leukocidin positive community-acquired methicillin-resistant Staphylococcus aureus in Bulgaria. Euro Surveill 2007; 12: pii: 3225.
  • 90
    Bartels MD, Boye K, Rhod Larsen A et al. Rapid increase of genetically diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerg Infect Dis 2007; 13: 15331540.
  • 91
    Monecke S, Slickers P, Ellington MJ et al. High diversity of Panton–Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 2007; 13: 11571164.
  • 92
    Krziwanek K, Luger C, Sammer B et al. PVL-positive MRSA in Austria. Eur J Clin Microbiol Infect Dis 2007; 26: 931935.
  • 93
    Witte W, Braulke C, Strommenger B. Community-associated methicillin-resistant Staphylococcus aureus ST8 (‘USA300’) in an HIV-positive patient in Cologne, Germany, February 2008. Euro Surveill 2008; 13: pii: 8080.
  • 94
    Vainio A, Karden-Lilja M, Ibrahem S et al. Clonality of epidemic methicillin-resistant Staphylococcus aureus strains in Finland as defined by several molecular methods. Eur J Clin Microbiol Infect Dis 2008; 27: 545555.
  • 95
    Fenner L, Widmer AF, Dangel M, Frei R. Distribution of spa types among meticillin-resistant Staphylococcus aureus isolates during a 6 year period at a low-prevalence university hospital. J Med Microbiol 2008; 57: 612616.
  • 96
    Otter JA, French GL. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clin Microbiol Infect 2008; 14: 670676.
  • 97
    Fang H, Hedin G, Li G, Nord CE. Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000–2005. Clin Microbiol Infect 2008; 14: 370376.
  • 98
    El Garch F, Hallin M, De Mendonca R et al. StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2009; 63: 877885.
  • 99
    Otter JA, Havill NL, Boyce JM, French GL. Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004–2006: where is USA300 in the UK? Eur J Clin Microbiol Infect Dis 2009; 28: 835839.
  • 100
    Ellington MJ, Perry C, Ganner M et al. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis 2009; 28: 11131121.
  • 101
    Daskalaki M, Rojo P, Marin-Ferrer M et al. Panton–Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clin Microbiol Infect 2009; 16: 7477.
  • 102
    Marchese A, Gualco L, Maioli E, Debbia E. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones. Int J Antimicrob Agents 2009; 34: 424428.
  • 103
    Grisold AJ, Zarfel G, Stoeger A et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria. J Infect 2009; 58: 168170.
  • 104
    Kanerva M, Salmenlinna S, Vuopio-Varkila J et al. Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004–2006. J Clin Microbiol 2009; 47: 26552657.
  • 105
    Cafiso V, Bertuccio T, Spina D et al. Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 2010; 29: 12771285.
  • 106
    Raulin O, Durand G, Gillet Y et al. Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection. J Clin Microbiol 2010; 48: 16961700.
  • 107
    Valsesia G, Rossi M, Bertschy S, Pfyffer GE. Emergence of SCCmec type IV and SCCmec type V methicillin-resistant Staphylococcus aureus containing the Panton–Valentine leukocidin genes in a large academic teaching hospital in central Switzerland: external invaders or persisting circulators? J Clin Microbiol 2010; 48: 720727.
  • 108
    Holzknecht BJ, Hardardottir H, Haraldsson G et al. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines. J Clin Microbiol 2010; 48: 42214227.
  • 109
    Ellington MJ, Ganner M, Smith IM et al. Panton–Valentine leucocidin-related disease in England and Wales. Clin Microbiol Infect 2010; 16: 8688.
  • 110
    Green SM, Marsh P, Ahmad N et al. Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK. J Med Microbiol 2010; 59: 10841088.
  • 111
    Otter JA, French GL. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital. Eur J Clin Microbiol Infect Dis 2011; 30: 459463.
  • 112
    Alvarellos CP, Carames LC, Castro SP et al. Usefulness of the restriction–modification test plus staphylococcal cassette chromosome mec types and Panton–Valentine leukocidin encoding phages to identify Staphylococcus aureus methicillin-resistant clones. Scand J Infect Dis 2011; 43: 943946.
  • 113
    Vergison A, Machado AN, Deplano A et al. Heterogeneity of disease and clones of community-onset methicillin-resistant Staphylococcus aureus in children attending a paediatric hospital in Belgium. Clin Microbiol Infect 2011; Jul 22. Doi: 10.1111/j.1469-0691.2011.03637.x. [Epub ahead of print].
  • 114
    Mithoe D, Rijnders MI, Roede BM et al. Prevalence of community-associated meticillin-resistant Staphylococcus aureus and Panton–Valentine leucocidin-positive S. aureus in general practice patients with skin and soft tissue infections in the northern and southern regions of The Netherlands. Eur J Clin Microbiol Infect Dis 2012; 31: 349356.
  • 115
    Di Giacobbe A, Pecetta S, Virga A et al. Diffusion of meticillin-resistant Staphylococcus aureus USA300 strains in central Italy. Int J Antimicrob Agents 2011; 37: 339346.
  • 116
    Nimmo GR, Schooneveldt JM, Sutherland JL et al. Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin. Eur J Clin Microbiol Infect Dis 2010; 29: 12531259.